Lobbying disclosures · Lobbying report
UNH: second_quarter 2026 lobbying report
Issues relating to Medicare Advantage; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act; Issues related to Senate Finance Dear Colleague process H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Follow UNH- Became public
- Jul 20, 2026, 2:31 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 10:00 PM EST
Why this is connected
Exact legal-name match: UNITEDHEALTH GROUP INC (https://www.sec.gov/Archives/edgar/data/731766/).
Reported lobbying amounts
Income: $120,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/aba161ae-942d-4aab-bff9-b0490c40e15d/","filing_uuid":"aba161ae-942d-4aab-bff9-b0490c40e15d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/aba161ae-942d-4aab-bff9-b0490c40e15d/print/","filing_document_content_type":"text/html","income":"120000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Tracy Spicer","dt_posted":"2026-07-20T14:31:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"401 9th St. NW","registrant_address_2":"Suite 720","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":72111,"url":"https://lda.gov/api/v1/registrants/72111/","house_registrant_id":35940,"name":"AVENUE SOLUTIONS","description":"Government representation","address_1":"401 9th St. NW","address_2":"Suite 720","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMY TEJRAL","contact_telephone":"+1 202-347-9848","dt_updated":"2026-07-30T13:56:38.410932-04:00"},"client":{"id":165764,"url":"https://lda.gov/api/v1/clients/165764/","client_id":113,"name":"UNITEDHEALTH GROUP INC","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-31"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues relating to Medicare Advantage; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act; Issues related to Senate Finance Dear Colleague process","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23462,"prefix":null,"prefix_display":null,"first_name":"TRACY","nickname":null,"middle_name":null,"last_name":"SPICER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149107,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"FUENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23462,"prefix":null,"prefix_display":null,"first_name":"TRACY","nickname":null,"middle_name":null,"last_name":"SPICER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149107,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"FUENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in UNH
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 13, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
$15K–$50K · Traded Sep 23, 2026 · disclosed Oct 13, 2026 · Joint
Committee overlap: Ways and MeansGot $26K from the company’s PAC - Oct 7, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
Sold (partial) UnitedHealth Group UNH
$1K–$15K · Traded Sep 24, 2026 · disclosed Oct 7, 2026
Got $9K from the company’s PAC - Sep 25, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
$15K–$50K · Traded Sep 10, 2026 · disclosed Sep 25, 2026 · Joint
Committee overlap: Ways and MeansGot $26K from the company’s PAC - Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 17, 2026$1K–$15K
Rep. Dan Newhouse (R-WA-4)
$1K–$15K · Traded Jul 10, 2026 · disclosed Jul 17, 2026 · Spouse
Traded 6 days before earnings - Jul 13, 2026$1K–$15K
Sen. John Boozman (R-AR)
$1K–$15K · Traded Jun 4, 2026 · disclosed Jul 13, 2026 · Joint
- Jul 9, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
Sold (partial) UnitedHealth Group UNH
$1K–$15K · Traded Jun 12, 2026 · disclosed Jul 9, 2026
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.